ILLUMINATIO MEDICAL TECHNOLOGY LIMITED

About ILLUMINATIO MEDICAL TECHNOLOGY LIMITED

Revolutionizing Early Disease Detection Through Advanced MRI Technology Illuminatio Medical Technology (IMT) is a pioneering medical imaging company that transforms standard MRI scanners into powerful diagnostic tools for early disease detection. Our breakthrough technology quantifies macromolecule levels in human tissues—solving a critical challenge in traditional MRI imaging. What Sets Us Apart: Our patented pulse sequence innovation works with existing MRI systems. Our non-invasive assessment requires no contrast agent injections. Our cost-effective workflow fits naturally into clinical routines. Our advanced post-processing software accelerates research-to-clinic translation. Addressing Critical Healthcare Needs: Our first commercial application targets liver fibrosis assessment, a crucial need affecting nearly 25% of the global population. With chronic liver disease creating substantial clinical and economic burdens worldwide, our non-invasive solution enables early, accurate diagnosis through MRI to guide treatment decisions and improve patient outcomes. Our Vision: We deliver comprehensive imaging diagnostic solutions to MRI manufacturers, healthcare providers, researchers, and clinical practitioners, bridging the gap between cutting-edge research and real-world clinical applications. Founded in 2021 by a multidisciplinary team from The Chinese University of Hong Kong, combining expertise in medical imaging engineering, clinical radiology, and business operation. Transforming MRI capabilities. Advancing patient care. Accelerating medical discovery.